Monast LC Syrup
By Monast LC
Rx
60ml Syrup in a Bottle

Composition
Levocetirizine(5mg) + Montelukast(10mg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
September, 2025

liver
When it comes to ensuring safety while using Monast LC Syrup, it's crucial to take caution especially if you have severe liver disease. In such cases, it is advisable to consult with your doctor as a dose adjustment may be necessary. The available information on the use of Monast LC Syrup in individuals with severe liver disease is limited, highlighting the importance of seeking medical advice before starting the medication. However, for patients with mild to moderate liver disease, no dose adjustment is typically required. It's always best to prioritize your liver health and communicate openly with your healthcare provider to ensure the safe and effective use of Monast LC Syrup.

kidney
Caution should be taken when using Monast LC Syrup in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor before use. This syrup is not recommended for individuals with severe kidney disease.

alcohol
When taking Monast LC Syrup, be cautious with alcohol consumption and consult your doctor.

driving
When using Monast LC Syrup, be cautious while driving as it may reduce alertness, cause vision problems, or lead to drowsiness and dizziness. Refrain from driving if experiencing these symptoms.

pregnancy
During pregnancy, Monast LC Syrup is generally safe to use. Animal studies indicate minimal harmful effects to the baby, but human studies are limited.

breastfeeding
Caution should be taken when breastfeeding while using Monast LC Syrup as it is considered unsafe. Research indicates potential toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹126.7
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024